Thyroid gland angiosarcoma

Summary

Thyroid gland angiosarcoma (MONDO:0003027) is a disease. A subtype of thyroid sarcoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	thyroid gland angiosarcoma
Mondo ID	MONDO:0003027
DOID	DOID:4514
NCIT	C6043
UMLS	C1336748
MedGen	277819
GARD	0023334
Anatomy (UBERON)	UBERON:0002046
Is cancer (heuristic)	no

Also known as: angiosarcoma (disease) of thyroid gland · angiosarcoma of the thyroid · angiosarcoma of the thyroid gland · angiosarcoma of thyroid · angiosarcoma of thyroid gland · hemangiosarcoma of the thyroid · hemangiosarcoma of the thyroid gland · hemangiosarcoma of thyroid · hemangiosarcoma of thyroid gland · thyroid angiosarcoma · thyroid gland angiosarcoma · thyroid gland angiosarcoma (disease) · thyroid gland hemangiosarcoma · thyroid gland malignant hemangioendothelioma · thyroid hemangiosarcoma

Disease family

This is a subtype of thyroid sarcoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › endocrine gland neoplasm › thyroid tumor › thyroid cancer › thyroid sarcoma › thyroid gland angiosarcoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.